TD Asset Management Inc Sells 28,070 Shares of Bruker Corporation $BRKR

Key Points

• TD Asset Management Inc reduced its stake in Bruker Corporation by 3.6%, selling 28,070 shares during the second quarter, and now holds 750,234 shares valued at approximately $30.91 million.
• Bruker reported a $0.32 EPS for the latest quarter, missing analyst estimates, with revenue down 0.4% year-over-year at $797.40 million.
• The company declared a quarterly dividend of $0.05 per share, reflecting an annualized yield of 0.5%, with an ex-dividend date set for September 23rd.

TD Asset Management Inc lowered its stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 3.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 750,234 shares of the medical research company's stock after selling 28,070 shares during the period. TD Asset Management Inc owned 0.50% of Bruker worth $30,910,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sculptor Capital LP raised its holdings in shares of Bruker by 51.6% in the 1st quarter. Sculptor Capital LP now owns 2,598,438 shares of the medical research company's stock valued at $108,459,000 after purchasing an additional 884,423 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Bruker by 107.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,465,319 shares of the medical research company's stock valued at $61,162,000 after purchasing an additional 758,301 shares during the period. AQR Capital Management LLC raised its stake in Bruker by 65.9% in the first quarter. AQR Capital Management LLC now owns 1,476,605 shares of the medical research company's stock valued at $60,688,000 after buying an additional 586,516 shares during the period. Vaughan Nelson Investment Management L.P. raised its stake in Bruker by 71.2% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 1,293,645 shares of the medical research company's stock valued at $53,298,000 after buying an additional 537,845 shares during the period. Finally, Nuveen LLC bought a new stake in Bruker in the first quarter valued at approximately $20,764,000. 79.52% of the stock is owned by institutional investors.

Bruker Stock Up 5.5%

BRKR stock opened at $38.20 on Friday. Bruker Corporation has a fifty-two week low of $28.53 and a fifty-two week high of $64.64. The stock has a market capitalization of $5.80 billion, a price-to-earnings ratio of 73.46, a PEG ratio of 5.07 and a beta of 1.20. The business's fifty day moving average price is $33.35 and its two-hundred day moving average price is $37.03. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business had revenue of $797.40 million for the quarter, compared to the consensus estimate of $811.17 million. During the same period in the prior year, the business posted $0.52 earnings per share. Bruker's revenue was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, equities analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd were paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Tuesday, September 23rd. Bruker's dividend payout ratio (DPR) is 38.46%.

Insider Buying and Selling

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of the firm's stock in a transaction on Friday, September 12th. The stock was sold at an average price of $32.25, for a total transaction of $114,003.75. Following the transaction, the director owned 18,016 shares in the company, valued at $581,016. This trade represents a 16.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 27.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Bank of America dropped their price target on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Wells Fargo & Company dropped their price objective on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Stifel Nicolaus set a $40.00 price objective on shares of Bruker and gave the company a "hold" rating in a research report on Tuesday, August 5th. Barclays dropped their price objective on shares of Bruker from $43.00 to $40.00 and set an "overweight" rating on the stock in a research report on Thursday, October 2nd. Finally, Citigroup lowered their price target on shares of Bruker from $40.00 to $38.00 and set a "neutral" rating on the stock in a report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $51.00.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.